Introduction
Ongoing retrospective surveillance of selected invasive pathogens isolated from blood and cerebrospinal fluid specimens at academic hospitals has been carried out for the past 30 years, initially by the Antibiotic Study Group of South Africa and subsequently by the National Antibiotic Surveillance Forum (NASF). 1 The NASF's key objectives include the monitoring of antimicrobial resistance patterns in the public and private health sectors in South Africa. 2 The public sector surveillance study reported here was confined to academic hospitals. Primary healthcare facilities and secondary hospitals which could have provided a broader base of patients exposed to antimicrobial selection pressure in different settings were not included. Based on this limitation and the lack of clinical information to assess treatment outcome, we were unable to recommend empirical antimicrobial treatment guidelines based of the findings of this survey. Here we present details of public sector laboratorybased surveillance of antimicrobial resistance for 2007 conducted at academic hospitals in South Africa.
Methodology
Participating National Health Laboratory Service (NHLS) laboratories (see Table 1 ) submitted data on specified organisms isolated from blood and cerebrospinal fluid. Duplicate isolates were excluded to minimise bias due to over-representation of those patients who were cultured most frequently. 3 To ensure quality, only data on final authorised results were included and all data were checked by a dedicated local pathologist before submission. Data were submitted quarterly and collated nationally. Antimicrobial susceptibilities were determined according to the contemporary 2007 Clinical and Laboratory Standards Institute (CLSI) criteria. 4 
Results and discussion
The antimicrobial susceptibilities of specified organisms are listed in Tables 2-7 . Different laboratories service varying combinations of primary, secondary and tertiary level hospitals and this may influence their resistance profile, for example Green Point laboratory serves predominantly primary level hospitals and this is reflected in the low levels of resistance with 70% of Staphylococcus aureus isolates at this laboratory susceptible to cloxacillin.
Among the Enterobacteriaceae (Table 2) , Klebsiella pneumoniae remains a highly resistant pathogen, with approximately half of all strains producing extended-spectrum beta-lactamases (ESBLs). These isolates were frequently multi-resistant with only 41-55% susceptible to gentamicin and 69-85% susceptible to ciprofloxacin. However, these figures are similar to those reported in 2004. 1 Retrospective antibiotic surveillance data of selected invasive pathogens isolated from blood and cerebrospinal fluid at public sector hospitals in South Africa in 2007 are presented. Antimicrobial 
Antimicrobial surveillance 2007
Escherichia coli strains exhibited less resistance than K. pneumoniae, with 73-89% susceptible to gentamicin, 79-88% susceptible to ciprofloxacin and only 9-26% producing ESBLs. Considerable resistance was also reported among Enterobacter spp, with ESBL rates ranging from 10-20%. Steve Biko Academic Hospital, Chris Hani Baragwanath Hospital and Tygerberg Hospital have the highest levels of resistance among Pseudomonas aeruginosa isolates as shown in Table 3 , while all laboratories reported considerable resistance among Acinetobacter spp. Variations in the percentage of carbapenem-resistant Acinetobacter spp. may be due to differences in reporting, with some laboratories reporting only on the Acinetobacter baumannii complex, which is generally more resistant than other Acinetobacter spp. About 50-60% of S. aureus isolates from blood were resistant to cloxacillin (see Table 5 ), indicating that methicillin-resistant S. aureus (MRSA) remains an important pathogen in South African hospitals. 
Streptococcus pneumoniae isolates from both blood and cerebrospinal fluid (

Concluding remarks
The major limitations of this laboratory-based study are the retrospective collection of data, susceptibility testing performed at each site, and lack of demographic data to distinguish community versus hospital-acquired infections and the failure to correlate clinical findings with antimicrobial resistance of isolates. In addition, the submission of blood and cerebrospinal fluid specimens for culture is dependent on clinicians whose test request practices may vary between different institutions. While attempts are made to ensure the quality of data, this report is dependent on the standards of laboratory practices maintained in the participating institutions. Considering these deficiencies, it would be beneficial to have a central reference facility for standardised surveillance, characterisation of multidrug-resistant pathogens, molecular typing of selected nosocomial pathogens and assistance with outbreak investigations and transmission prevention of resistant pathogens at national level.
Despite the limitations outlined above, we may conclude that the numbers of resistant pathogens, particularly MRSA and ESBLproducing K. pneumoniae, remain high in most institutions in the public sector in 2007 and that ongoing regular surveillance is indicated. 
